Search results
Govt May Consider Using mRNA HPV Vaccine Against Cervical Cancer For Older Women - News18
News18· 4 hours agoThe central government may use messenger ribonucleic acid (mRNA) based vaccines for running a...
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India
Business Standard India· 22 hours agoThe agreement allows Mankind Pharma to launch the novel drug for treating Gastroesophageal Reflux...
STI’s Namita Thapar roots for inclusive surrogacy laws amid rising infertility rate
Pinkvilla· 3 days agoNamita Thapar is a Shark Tank India judge and a businesswoman. In a recent Instagram post, Thapar...
Emcure Pharmaceuticals Share Price Today: Live NSE/BSE Emcure Pharmaceuticals Stock Price,...
Financial Express· 6 days agoEmcure Pharmaceuticals Ltd., operating in the Pharmaceuticals sector and classified as a Largecap on the bse, currently has its share ...
Shark tank fame Namita Thapar shares an emotional Mirza Ghalib shayari post Emcure IPO's robust...
The Economic Times· 6 days agoShark Tank fame Namita Thapar took to social media to share an emotional note following the listing...
...Pharmace Share Price, Emcure Pharmace Stock Price, Emcure Pharmaceuticals Ltd. Stock Price, Share...
CNBC Awaaz· 6 days agoEmcure Pharmace Share Price: Find the latest news on Emcure Pharmace Stock Price. Get all the information on Emcure Pharmace with historic ...
Namita Thapar in emotional X post congratulates Emcure Pharma team on 31% premium listing, , quotes...
Livemint· 7 days agoEmcure Pharmaceuticals’ stock opened at ₹1,325.05, up 31.45 per cent on both the BSE and the NSE on...
Emcure Pharmaceuticals Ltd. Monthly Technical Analysis | Stochastic RSI indicators
CNBC Awaaz· 7 days agoIt is a momentum indicator used to identify overbought or oversold condition in the stock.Time period generally considered is 14 days. RSI reading below 25 is interpreted as oversold. RSI between ...
Emcure Pharmaceuticals Lists at 31% Premium on the Bourses | India Infoline
India Infoline· 7 days agoThe IPO comprised a mix of fresh equity sale and an offer for sale (OFS).
Emcure Pharma Soars 34.8% on NSE at Close | India Infoline
India Infoline· 7 days agoThe allotment of shares was finalised on July 8, and Emcure Pharma shares were scheduled to be listed on the BSE and NSE on July 10.